Guidelines for Neuroleptic Relapse Prevention in Schizophrenia : Proceedings of a Consensus Conference Held April 19–20, 1989, in Bruges, Belgium

How neuroleptics are used in relapse prevention is a very controversial topic. Fifty percent of all schizo- phrenic patients do not receive sufficient prophylactic treatment and suffer from frequent relapses. To help correct this situation, leading international experts in the field of neuroleptic relapse prevention (n.r.p.) agreed upon guidelines after intensive discussions at a consensus workshop in Bruges in April 1989. Precise guidelines to the most important questions on n.r.p. are formu- lated, especially concerning indications, treatment duration and dosage. The current state of the literature on these questions is presented in comprehensive reviews. For the practicing psychiatrist or general practitioner, exact guidelines for prophylactic treatment are presented; for patients and their families eager to obtain more information, the scientific basis of the treatment is explained. Front Matter....Pages I-IX Introduction....Pages 1-6 Front Matter....Pages 7-7 United States: Neuroleptic Relapse Prevention....Pages 9-12 Austria: The Current Status of Maintenance Treatment in Schizophrenia....Pages 13-15 United Kingdom: Neuroleptic Relapse Prevention....Pages 16-23 Sweden: Neuroleptic Relapse Prevention....Pages 24-25 Sweden: Neuroleptic Treatment Strategies and Practical Problems During Drugs Withdrawal....Pages 26-29 Federal Republic of Germany: Neuroleptic Relapse Prevention....Pages 30-33 Federal Republic of Germany: Maintenance Neuroleptic Treatment in Schizophrenia....Pages 34-37 United States: Neuroleptic Relapse Prevention....Pages 38-44 United Kingdom: Neuroleptic Relapse Prevention....Pages 45-48 Switzerland: Neuroleptic Relapse Prevention....Pages 49-49 Federal Republic of Germany: Neuroleptic Relapse Prevention....Pages 50-52 Front Matter....Pages 53-53 The Interaction of Drug and Family Therapy in the Prevention of Relapse in Schizophrenia....Pages 55-66 Predictors of Risk of Relapse in Schizophrenia....Pages 67-77 Who Should Be Treated?....Pages 78-84 Dosage and Route of Administration of Neuroleptic Drugs During Different Phases of a Schizophrenic Illness....Pages 85-93 Duration of Neuroleptic Maintenance Treatment....Pages 94-112 Front Matter....Pages 113-113 General Discussion....Pages 115-151 Front Matter....Pages 153-153 Guidelines for Neuroleptic Relapse Prevention in Schizophrenia: Towards a Consensus View....Pages 155-163 Back Matter....Pages 165-166